Rogaine first year sales trending at over $100 mil. based on IRI data through November.
This article was originally published in The Tan Sheet
Executive Summary
ROGAINE FIRST YEAR OTC SALES TRENDING AT OVER $100 MIL., according to data from Information Resources, Inc. Launched in April, the Rx-to-OTC switch product showed sales through November of $96.8 mil. in food, drug and mass merchandiser outlets, constituting an 86.8% dollar share of the hair regrowth market. Pharmacia & Upjohn has predicted that five-year OTC Rogaine sales will total $650 mil. ("The Tan Sheet" May 13, 1996, In Brief)